Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker

H Suh-Kim, X Wei and L Birnbaumer

Department of Anatomy, Ajou University, Suwon, Korea.

Skeletal muscle L-type channels are the pharmacological receptors for Ca2+ channel antagonists, including dihydropyridines (DHPs). High affinity DHP binding to these channels in skeletal muscle membranes has been reported to be independent of Ca2+ addition and to become dependent on Ca2+ after solubilization. The channel is a multimeric complex composed of alpha 1, beta, gamma, and alpha 2 delta, of which alpha 1 is the pore-forming and DHP-binding component. In this study we coexpressed non-alpha 1 components with alpha 1 in L and COS cells and investigated their roles in the regulation of high affinity DHP binding by Mg2+ and Ca2+. No DHP binding to membranes of cells expressing alpha 1 beta alone was detected in the absence of Ca2+ or Mg2+. Addition of Mg2+ revealed the presence of (+)-PN200-110 (DHP) binding sites with a Kd of 1 nM. This affinity was 4-fold lower than that of skeletal muscle membrane binding sites (Kd = 0.25 nM). Addition of Ca2+ increased the affinity for DHP in membranes from alpha 1 beta-expressing cells to that seen in skeletal muscle membranes (Kd = 0.2-0.3 nM; EC50 of 0.2 microM). Ca2+ did not affect DHP binding to skeletal muscle membranes. Coexpression of all of the subunits completely recapitulated the high affinity DHP binding seen with skeletal muscle membranes in the absence of Ca2+ and Mg2+ (Kd = 0.15 nM). This affinity was unaffected by addition of Ca2+ or Mg2+. Coexpression of alpha 1 beta with either alpha 2 delta or gamma alone resulted in DHP binding intermediate between levels seen with alpha 1 beta and alpha 1 beta alpha 2 delta gamma. Thus, this study demonstrates that alpha 2 delta and gamma are essential for full reconstitution of the DHP binding characteristics of the skeletal muscle L-type Ca2+ channel/DHP receptor.

Volume 50, Issue 5, pp. 1330-1337, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Z. Andronache, D. Ursu, S. Lehnert, M. Freichel, V. Flockerzi, and W. Melzer The auxiliary subunit {gamma}1 of the skeletal muscle L-type Ca2+ channel is an endogenous Ca2+ antagonist PNAS, November 6, 2007; 104(45): 17885 - 17890. [Abstract] [Full Text] [PDF]

				S. Herzig, I. F. Y. Khan, D. Grundemann, J. Matthes, A. Ludwig, G. Michels, U. C. Hoppe, D. Chaudhuri, A. Schwartz, D. T. Yue, et al. Mechanism of Cav1.2 channel modulation by the amino terminus of cardiac {beta}2-subunits FASEB J, May 1, 2007; 21(7): 1527 - 1538. [Abstract] [Full Text] [PDF]

				N. Qin, R. Olcese, E. Stefani, and L. Birnbaumer Modulation of human neuronal alpha 1E-type calcium channel by alpha 2delta -subunit Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1324 - C1331. [Abstract] [Full Text] [PDF]

				M. Pichler, T. N. Cassidy, D. Reimer, H. Haase, R. Kraus, D. Ostler, and J. Striessnig beta Subunit Heterogeneity in Neuronal L-type Ca2+ Channels J. Biol. Chem., May 23, 1997; 272(21): 13877 - 13882. [Abstract] [Full Text] [PDF]

				H. Safayhi, H. Haase, U. Kramer, A. Bihlmayer, M. Roenfeldt, H. P.T. Ammon, M. Froschmayr, T. N. Cassidy, I. Morano, M. K. Ahlijanian, et al. L-Type Calcium Channels in Insulin-Secreting Cells: Biochemical Characterization and Phosphorylation in RINm5F Cells Mol. Endocrinol., May 1, 1997; 11(5): 619 - 629. [Abstract] [Full Text]

				M.-G. Kang, C.-C. Chen, R. Felix, V. A. Letts, W. N. Frankel, Y. Mori, and K. P. Campbell Biochemical and Biophysical Evidence for gamma 2 Subunit Association with Neuronal Voltage-activated Ca2+ Channels J. Biol. Chem., August 24, 2001; 276(35): 32917 - 32924. [Abstract] [Full Text] [PDF]